Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Editorial Enquiries – GOLD
Editorial Enquiries – EMJ
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Editorial Enquiries – GOLD
Editorial Enquiries – EMJ
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Urology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Ureterocutaneous Fistula in Setting of Recurrent Gluteal Abscesses
6
Mins
March 2024
Ureteral fistulas are a rare occurrence, and are most commonly the result of iatrogenic trauma, although other causes include radiation…
Read more
4
Mins
12th December 2022
Interview: Christopher Chapple
EMJ spoke to Christopher Chapple about his role as Secretary General of the European Association of Urology (EAU)…
11
Mins
26th October 2022
Recent Advances in the First-Line Management of Advanced Renal Cell Carcinoma: Focus on the Role of Lenvatinib Plus Pembrolizumab Combination Treatment
As part of the 37th Annual European Association of Urology (EAU) Congress, this symposium presented key data from the CLEAR study: a Phase III randomised controlled trial evaluating lenvatinib plus pembrolizumab versus sunitinib in patients with advanced renal cell carcinoma (RCC) in the first-line (1L) setting.
8
Mins
20th September 2022
Management of Acute and Recurrent Urinary Tract Infections Caused by Resistant Pathogens
At least 60% of females worldwide will experience at least one UTI in their lifetime.4 An array of pathogenic bacteria, both gram-negative and gram-positive, can cause the infections, although in uUTIs, Escherichia coli (E. coli) is the predominant pathogen.
9
Mins
15th August 2022
Improvements in Prostate Cancer Management: Focus on Imaging and Treatment
Imaging has a pivotal role in the staging of primary prostate cancer, as well as in determining optimal management strategies.
9
Mins
15th August 2022
Pigmentary Maculopathy in Interstitial Cystitis/Bladder Pain Syndrome Treated with Oral Pentosan Polysulfate: A Review
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic condition of unknown aetiology. Symptoms can vary but there is typically pelvic pain or discomfort perceived to be related to the urinary bladder, usually accompanied by other urinary symptoms such as the persistent urge to void or frequency.
10
Mins
15th August 2022
Advancing Patient Care in the Evolving Prostate Cancer Treatment Landscape
Prostate cancer varies at initial diagnosis and in its progression, with non-metastatic and metastatic presentations that may or may not respond to ADT (Figure 1).
8
Mins
15th August 2022
Interview: Prasanna Sooriakumaran
Prasanna Sooriakumaran | Lead for Urology and Consultant Urological Surgeon, Cleveland Clinic London, UK; Consultant Urological and Robotic Surgeon, University College London Hospitals; Honorary Senior Clinical Researcher, University of Oxford, UK.
5
Mins
13th July 2022
Primary Renal Hydatid in Children
Isolated renal hydatid disease, caused by the larvae of the parasitic tapeworm Echinococcus granulosus is a rare phenomenon and accounts…
Loading posts...
« Previous
1
2
3
4
5
…
22
Next »